Abstract
BackgroundPatients admitted to the emergency department (ED) with COVID-19 symptoms are routinely required to have chest radiographs and computed tomography (CT) scans. COVID-19 infection has been directly related to the development of acute respiratory distress syndrome (ARDS) and severe infections could lead to admission to intensive care and increased risk of death. The use of clinical data in machine learning models available at time of admission to ED can be used to assess possible risk of ARDS, the need for intensive care (admission to the Intensive Care Unit; ICU) as well as risk of mortality. In addition, chest radiographs can be inputted into a deep learning model to further assess these risks. PurposeThis research aimed to develop machine and deep learning models using both structured clinical data and image data from the electronic health record (EHR) to predict adverse outcomes following ED admission. Materials and MethodsLight Gradient Boosting Machine (LightGBM) was used as the main machine learning algorithm using all clinical data including 42 variables. Compact models were also developed using the 15 most important variables to increase applicability of the models in clinical settings. To predict risk (or early stratified risk) of the aforementioned health outcome events, transfer learning from the CheXNet model was also implemented on the available data. This research utilized clinical data and chest radiographs of 3,571 patients, 18 years and older, admitted to the emergency department between 9th March 2020 and 29th October 2020 at Loyola University Medical Center. Main FindingsThe research results show that we can detect COVID-19 infection (AUC = 0.790 (0.746–0.835)), predict the risk of developing ARDS (AUC = 0.781 (0.690–0.872), risk stratification of the need for ICU admission (AUC = 0.675 (0.620–0.713)) and mortality (AUC = 0.759 (0.678–0.840)) at moderate accuracy from both chest X-ray images and clinical data. Principal ConclusionsThe results can help in clinical decision making, especially when addressing ARDS and mortality, during the assessment of patients admitted to the ED with or without COVID-19 symptoms.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.